NK cells for cancer immunotherapy

N Shimasaki, A Jain, D Campana - Nature reviews Drug discovery, 2020 - nature.com
Natural killer (NK) cells can swiftly kill multiple adjacent cells if these show surface markers
associated with oncogenic transformation. This property, which is unique among immune …

Natural killer cell cytotoxicity and its regulation by inhibitory receptors

S Kumar - Immunology, 2018 - Wiley Online Library
Natural killer (NK) cells express an array of germ‐line encoded receptors that are capable of
triggering cytotoxicity. NK cells tend to express many members of a given family of signalling …

The mechanism of anti–PD-L1 antibody efficacy against PD-L1–negative tumors identifies NK cells expressing PD-L1 as a cytolytic effector

W Dong, X Wu, S Ma, Y Wang, AP Nalin, Z Zhu… - Cancer discovery, 2019 - AACR
Blockade of PD-L1 expression on tumor cells via anti–PD-L1 monoclonal antibody (mAb)
has shown great promise for successful cancer treatment by overcoming T-cell exhaustion; …

Eomes-dependent loss of the co-activating receptor CD226 restrains CD8+ T cell anti-tumor functions and limits the efficacy of cancer immunotherapy

M Weulersse, A Asrir, AC Pichler, L Lemaitre, M Braun… - Immunity, 2020 - cell.com
CD8+ T cells within the tumor microenvironment (TME) are exposed to various signals that
ultimately determine functional outcomes. Here, we examined the role of the co-activating …

TIGIT/CD226 axis regulates anti-tumor immunity

J Yeo, M Ko, DH Lee, Y Park, H Jin - Pharmaceuticals, 2021 - mdpi.com
Tumors escape immune surveillance by inducing various immunosuppressive pathways,
including the activation of inhibitory receptors on tumor-infiltrating T cells. While monoclonal …

Research progress on NK cell receptors and their signaling pathways

Y Chen, D Lu, A Churov, R Fu - Mediators of Inflammation, 2020 - Wiley Online Library
Natural killer cells (NK cells) play an important role in innate immunity. NK cells recognize
self and nonself depending on the balance of activating receptors and inhibitory receptors …

Tumor intrinsic and extrinsic immune functions of CD155

JS O'Donnell, J Madore, XY Li, MJ Smyth - Seminars in cancer biology, 2020 - Elsevier
Abstract CD155 (PVR/necl5/Tage4), a member of the nectin-like family of adhesion
molecules, is highly upregulated on tumor cells across multiple cancer types and has been …

CD155 on tumor cells drives resistance to immunotherapy by inducing the degradation of the activating receptor CD226 in CD8+ T cells

M Braun, AR Aguilera, A Sundarrajan, D Corvino… - Immunity, 2020 - cell.com
The activating receptor CD226 is expressed on lymphocytes, monocytes, and platelets and
promotes anti-tumor immunity in pre-clinical models. Here, we examined the role of CD226 …

Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization

S Chen, H Zhu, Y Jounaidi - Signal Transduction and Targeted Therapy, 2024 - nature.com
Natural killer (NK) cells, initially identified for their rapid virus-infected and leukemia cell
killing and tumor destruction, are pivotal in immunity. They exhibit multifaceted roles in …

Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2

Y Jo, HI Sim, B Yun, Y Park, H Jin - Experimental & Molecular Medicine, 2024 - nature.com
Cancer immunotherapy aims to initiate or amplify immune responses that eliminate cancer
cells and create immune memory to prevent relapse. Immune checkpoint inhibitors (ICIs) …